Supplementary Major Medical

Supplementary Major Medical insurance is a type of health insurance policy that helps cover some or all of the costs associated with medical treatment and hospitalization, including deductibles, copayments, and coinsurance. It is designed to provide additional coverage on top of an existing health insurance policy or as a standalone policy. Here are some key features of Supplementary Major Medical insurance:

  • Provides coverage for medical expenses beyond what is covered by a primary health insurance policy
  • Helps to cover deductibles, coinsurance, and copayments
  • May provide coverage for medical services that are not covered by a primary health insurance policy
  • May have a higher annual limit on benefits than a primary health insurance policy
  • Can be purchased as a standalone policy or as an add-on to an existing health insurance policy

Here's an example of how Supplementary Major Medical insurance works:  

Let's say you have a health insurance policy with a $2,000 deductible and a 20% coinsurance requirement. You're admitted to the hospital for a procedure that costs $10,000. After you've paid your $2,000 deductible, you're responsible for 20% of the remaining $8,000, or $1,600. If you have Supplementary Major Medical insurance with a $5,000 limit, your policy would cover the remaining $3,400 of your medical expenses.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.